ANGPTL3 and deep vein thrombosis: Simulating the gene effects weighted on Apo-B garnered similar outcomes (refer to Fig. 3, Tables S7–S9, Supplemental Digital Content, http://links.lww.com/MD/O85, http://links.lww.com/MD/O85, http://links.lww.com/MD/O85), although mimicking the inhibition of ANGPTL3 equivalent to a one standard deviation drop in Apo-B correlated with a decreased risk of VTE, DVT, and PE.